301 related articles for article (PubMed ID: 38033434)
1. Recent Advances in Serum Biomarkers for Cardiological Risk Stratification and Insight into the Cardiac Management of the Patients With Hematological Malignancies Treated With Targeted Therapy.
Andreescu M
Cureus; 2023 Nov; 15(11):e49696. PubMed ID: 38033434
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology.
Joolharzadeh P; Rodriguez M; Zaghlol R; Pedersen LN; Jimenez J; Bergom C; Mitchell JD
Curr Cardiol Rep; 2023 Mar; 25(3):133-146. PubMed ID: 36790618
[TBL] [Abstract][Full Text] [Related]
3. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
[TBL] [Abstract][Full Text] [Related]
4. Applied Cardio-Oncology in Hematological Malignancies: A Narrative Review.
Mandala E; Lafara K; Kokkinovasilis D; Kalafatis I; Koukoulitsa V; Katodritou E; Lafaras C
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672794
[TBL] [Abstract][Full Text] [Related]
5. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
6. Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians.
Johnson CB; Sulpher J; Stadnick E
Curr Opin Cardiol; 2015 Mar; 30(2):197-204. PubMed ID: 25574894
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Complications in the Adult Bone Marrow Transplant Patient.
Tuzovic M; Mead M; Young PA; Schiller G; Yang EH
Curr Oncol Rep; 2019 Mar; 21(3):28. PubMed ID: 30826891
[TBL] [Abstract][Full Text] [Related]
8. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
9. Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity.
Čiburienė E; Aidietienė S; Ščerbickaitė G; Brasiūnienė B; Drobnienė M; Baltruškevičienė E; Žvirblis T; Čelutkienė J
J Cardiovasc Dev Dis; 2022 Apr; 9(5):. PubMed ID: 35621845
[TBL] [Abstract][Full Text] [Related]
10. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
Domercant J; Polin N; Jahangir E
Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
13. The Role of Biomarkers to Evaluate Cardiotoxicity.
Upshaw JN
Curr Treat Options Oncol; 2020 Aug; 21(10):79. PubMed ID: 32767198
[TBL] [Abstract][Full Text] [Related]
14. The role of cardiac biomarkers in cardio-oncology.
Riddell E; Lenihan D
Curr Probl Cancer; 2018 Jul; 42(4):375-385. PubMed ID: 30126650
[TBL] [Abstract][Full Text] [Related]
15. Precision Cardio-Oncology.
Dreyfuss AD; Bravo PE; Koumenis C; Ky B
J Nucl Med; 2019 Apr; 60(4):443-450. PubMed ID: 30655328
[TBL] [Abstract][Full Text] [Related]
16. Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology.
Spannbauer A; Bergler-Klein J
Hamostaseologie; 2024 May; ():. PubMed ID: 38723641
[TBL] [Abstract][Full Text] [Related]
17. Cardio-oncology: A Focus on Cardiotoxicity.
Koutsoukis A; Ntalianis A; Repasos E; Kastritis E; Dimopoulos MA; Paraskevaidis I
Eur Cardiol; 2018 Aug; 13(1):64-69. PubMed ID: 30310475
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity screening of long-term, breast cancer survivors-The CAROLE (Cardiac-Related Oncologic Late Effects) Study.
Puckett LL; Saba SG; Henry S; Rosen S; Rooney E; Filosa SL; Gilbo P; Pappas K; Laxer A; Eacobacci K; Kapyur AN; Robeny J; Musial S; Chaudhry A; Chaudhry R; Lesser ML; Riegel A; Ramoutarpersaud S; Rahmani N; Shah A; Papas V; Dawodu T; Charlton J; Knisely JPS; Lee L
Cancer Med; 2021 Aug; 10(15):5051-5061. PubMed ID: 34245128
[TBL] [Abstract][Full Text] [Related]
19. [Curing cancer and protecting the heart : Challenges in cardio-oncology in the era of modern tumor treatment].
Hohmann C; Baldus S; Pfister R
Herz; 2019 Apr; 44(2):175-188. PubMed ID: 30847511
[TBL] [Abstract][Full Text] [Related]
20. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
Rygiel K
Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
